Carregant...
Critical appraisal of ticagrelor in the management of acute coronary syndrome
Ticagrelor is a novel P2Y(12) receptor antagonist which, like clopidogrel and prasugrel, functions by blocking adenosine diphosphate-mediated platelet aggregation. However, unlike the aforementioned agents, the binding of ticagrelor to this receptor is reversible. Ticagrelor is also believed to medi...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove Medical Press
2011
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3253754/ https://ncbi.nlm.nih.gov/pubmed/22241944 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S19835 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|